Phase 4 B-cell Lymphoma Clinical Trials
3 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–3 of 3 trials
Recruiting
Phase 4
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
B-cell LymphomaHemophagocytic Lymphohistiocytosis
The First Affiliated Hospital of Soochow University40 enrolled1 locationNCT07270835
Recruiting
Phase 4
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
Relapsed or Refractory B-cell Lymphoma
Ruijin Hospital8 enrolled1 locationNCT05806580
Recruiting
Phase 3Phase 4
Outpatient Ifosfamide, Etoposide plus Rituximab (R-IE) for salvage in patients > 60 years with relapsed or refractory CD20 positive diffuse large B-cell lymphoma who are not candidates for stem cell transplant study
Relapsed or refractory CD20 positive diffuse large B-cell lymphoma
Roche40 enrolled1 locationACTRN12606000373572